The House resumed consideration of Bill C-64, An Act respecting pharmacare, as reported (with amendments) from the committee, and of the motions in Group No. 1.
In the House of Commons on May 30th, 2024. See this statement in context.
In the House of Commons on May 30th, 2024. See this statement in context.
The House resumed consideration of Bill C-64, An Act respecting pharmacare, as reported (with amendments) from the committee, and of the motions in Group No. 1.
See context to find out what was said next.